Suchergebnisse - "Vekemans, Johan"

PubPharm (174)

1

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) : 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults

enthalten in: Human vaccines & immunotherapeutics | 2024

von Kulkarni, P. | Padmapriyadarsini, C. | Vekemans, J. | +29

2

What is next for BCG revaccination to prevent tuberculosis?

enthalten in: The Lancet. Respiratory medicine | 2024

von White, R. | Fiore-Gartland, A. | Hanekom, W. | +8

3

An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine Trials

enthalten in: The Journal of infectious diseases | 2023

von Hill, P. | Cobelens, F. | Martinez, L. | +9

CommentIn: J Infect Dis. 2023 Nov 2;228(9):1147-1149. - PMID 37602513

4

Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults : a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland

enthalten in: The Lancet. Microbe | 2023

von Ramasamy, M. | Kelly, E. | Seegobin, S. | +51

5

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials : why and how?

enthalten in: The Lancet. Microbe | 2023

von Nelson, K. | Churchyard, G. | Cobelens, F. | +10

6

Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment

enthalten in: The Lancet. Respiratory medicine | 2023

von Rangaka, M. | Frick, M. | Churchyard, G. | +9

7

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya : an open-label, phase 2b, randomised controlled trial

enthalten in: The Lancet. Infectious diseases | 2022

von Samuels, A. | Ansong, D. | Kariuki, S. | +38

CommentIn: Lancet Infect Dis. 2022 Sep;22(9):1258-1259. - PMID 35753319

8

Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan : a double-blind, randomized controlled phase 1/2 trial

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Asano, M. | Okada, H. | Itoh, Y. | +8

9

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India

enthalten in: EClinicalMedicine | 2021

von Kulkarni, P. | Padmapriyadarsini, C. | Vekemans, J. | +29

10

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

enthalten in: Nature medicine | 2021

von Feng, S. | Phillips, D. | White, T. | +96

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]